2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow SHR-9839(sc) for Injection: new trials by email Literature Review of SHR-9839(sc) for Injection trials Research Report on SHR-9839(sc) for Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma SHR-9839(sc) for Injection, SHR-9839(sc) for Injection、Adebrelimab Injection、Paclitaxel for Injection、Cisplatin Injecion - Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 84 | 2026-09-07 | 2026-09-16 |
| A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors SHR-9839(sc) For Injection - Solid Tumor | Phase 1 / Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 70 | 2026-02-27 | 2026-03-20 |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. (2)
China (2)